Cancer stem cells--old concepts, new insights
- PMID: 18259194
- DOI: 10.1038/cdd.2008.20
Cancer stem cells--old concepts, new insights
Abstract
Cancer has long been viewed as an exclusively genetic disorder. The model of carcinogenesis, postulated by Nowell and Vogelstein, describes the formation of a tumor by the sequential accumulation of mutations in oncogenes and tumor suppressor genes. In this model, tumors are thought to consist of a heterogeneous population of cells that continue to acquire new mutations, resulting in a highly dynamic process, with clones that out compete others due to increased proliferative or survival capacity. However, novel insights in cancer stem cell research suggest another layer of complexity in the process of malignant transformation and preservation. It has been reported that only a small fraction of the cancer cells in a malignancy have the capacity to propagate the tumor upon transplantation into immuno-compromised mice. Those cells are termed 'cancer stem cells' (CSC) and can be selected based on the expression of cell surface markers associated with immature cell types. In this review, we will critically discuss these novel insights in CSC-related research. Where possible we integrate these results within the genetic model of cancer and illustrate that the CSC model can be considered an extension of the classic genetic model rather than a contradictory theory. Finally, we discuss some of the most controversial issues in this field.
Similar articles
-
Pluripotent human stem cell lines: what we can learn about cancer initiation.Trends Mol Med. 2008 Aug;14(8):323-32. doi: 10.1016/j.molmed.2008.06.005. Epub 2008 Jul 16. Trends Mol Med. 2008. PMID: 18635398
-
Cancer stem cells: a guide for skeptics.J Cell Biochem. 2009 Apr 1;106(5):745-9. doi: 10.1002/jcb.22050. J Cell Biochem. 2009. PMID: 19184979 Review.
-
Defining the steps that lead to cancer: replicative telomere erosion, aneuploidy and an epigenetic maturation arrest of tissue stem cells.Med Hypotheses. 2008;71(1):126-40. doi: 10.1016/j.mehy.2008.01.010. Epub 2008 Feb 21. Med Hypotheses. 2008. PMID: 18294777
-
Stem cells in the etiology and treatment of cancer.Curr Opin Genet Dev. 2006 Feb;16(1):60-4. doi: 10.1016/j.gde.2005.12.008. Epub 2005 Dec 27. Curr Opin Genet Dev. 2006. PMID: 16377171 Review.
-
Die hard: are cancer stem cells the Bruce Willises of tumor biology?Cytometry A. 2009 Jan;75(1):67-74. doi: 10.1002/cyto.a.20690. Cytometry A. 2009. PMID: 19051297 Review.
Cited by
-
Cancer heterogeneity--a multifaceted view.EMBO Rep. 2013 Aug;14(8):686-95. doi: 10.1038/embor.2013.92. Epub 2013 Jul 12. EMBO Rep. 2013. PMID: 23846313 Free PMC article. Review.
-
TACC3 promotes stemness and is a potential therapeutic _target in hepatocellular carcinoma.Onco_target. 2015 Sep 15;6(27):24163-77. doi: 10.18632/onco_target.4643. Onco_target. 2015. PMID: 26219398 Free PMC article.
-
Cancer stem cells: the challenges ahead.Nat Cell Biol. 2013 Apr;15(4):338-44. doi: 10.1038/ncb2717. Nat Cell Biol. 2013. PMID: 23548926
-
_targeting cancer stem cell plasticity in triple-negative breast cancer.Explor _target Antitumor Ther. 2023;4(6):1165-1181. doi: 10.37349/etat.2023.00190. Epub 2023 Dec 11. Explor _target Antitumor Ther. 2023. PMID: 38213533 Free PMC article. Review.
-
AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells.Oncogene. 2014 Mar 6;33(10):1316-24. doi: 10.1038/onc.2013.57. Epub 2013 Mar 11. Oncogene. 2014. PMID: 23474758 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
